News &amp; Updates

Consuming meat at an amount higher than conventionally recommended appears to be associated with favourable cognitive health outcomes and reduced dementia risk in the specific subgroup of individuals carrying the Alzheimer’s disease (AD) genetic risk modifier APOE34/44, as reported in a study.

Antiobesity drugs plus behavioural treatment induces more weight loss than medication alone

Oral antiobesity medications (AOMs) combined with behavioural treatment via telemedicine induces greater weight loss than medications alone, a study has shown.

Avacincaptad pegol slows geographic atrophy progression

Patients with noncentre point-involving geographic atrophy (GA) who receive avacincaptad pegol (ACP) 2 mg every month (EM) or every other month (EOM) show a persistent decrease in GA growth over 2 years relative to sham therapy, with no new safety signals, according to the GATHER2 study.

27 Mar 2026

Laser iridotomy tied to sustained angle widening in eyes

Laser peripheral iridotomy (LPI) brings sustained angle widening to about two-thirds of patients with persistent angle closure, reports a study.

2-year data support nerve-sparing technique in prostate cancer surgery

An updated 24-month analysis of the NeuroSAFE PROOF study continues to support robot-assisted radical prostatectomy (RARP) guided by the nerve-sparing NeuroSAFE technique in men with prostate cancer.

27 Mar 2026

Fenofibrate beneficial in PBC patients with insufficient response to ursodeoxycholic acid

In patients with primary biliary cholangitis (PBC) with insufficient response to ursodeoxycholic acid, outcomes appear to improve following treatment with fenofibrate, as shown in a single-centre retrospective cohort study.

CKM outcomes in HK after reclassifying obesity by the Lancet Commission’s definition

In an observational study of two community-based cohorts in Hong Kong, 6.7 percent of individuals with BMI ≥25 kg/m² were reclassified as nonobese after applying the Lancet Commission’s definition of obesity. Individuals with clinical obesity had the highest risk of adverse cardiovascular-kidney-metabolic (CKM) outcomes, while those reclassified as nonobese had an intermediate risk.

27 Mar 2026

Psilocybin superior to nicotine patch for helping smokers quit

26 Mar 2026 by

A single dose of psilocybin, when combined with cognitive behavioural therapy (CBT), may significantly increase the rate of long-term abstinence compared with nicotine patch treatment, according to the results of a randomized clinical trial.

What is the optimal MPA dosing to prevent relapse in paediatric nephrotic syndrome?

A study suggests maintaining mycophenolic acid (MPA) area under the concentration‒time curve (AUC0‒12h) ≥31.51 μg/h/mL to significantly lower the risk of relapse in paediatric patients with nephrotic syndrome (NS).

Bladder problems burden people with multiple sclerosis

26 Mar 2026 by

Bladder dysfunction is among the top 10 most frequently reported functional domains affecting people living with multiple sclerosis (MS), reports a study presented at EAU 2026.